Gasdermin C activation boosts type II immunity against helminths, and NSAIDs may someday offer a novel, repurposed treatment ...

Sarepta Therapeutics said it will voluntarily “and temporarily” pause all shipments of Elevidys® (delandistrogene ...

Three applications for gene editing in conservation are restoring lost variation and facilitated adaptation as well as reducing harmful mutations.

VISTA, an AI-controlled data loop system, guides large-scale antibody design from scratch for applications in cancer therapy.

Biogen said it intends to invest an additional $2 billion to expand operations at its largest manufacturing facilities within North Carolina’s Research Triangle Park (RTP).

Study harnesses a cell-type-specific, multi-target drug discovery strategy grounded in human data and real-world evidence.

Using data from the T2T reference, scientists linked two new genes to changes in brain size and synapse signaling.

An antibody treatment successfully prepared patients for stem cell transplants without toxic chemotherapy or radiation.